annual cost of heart disease in the us
If your State wants to includeother examples that are more relevant to current issues, feel free to do so. The Cost of Heart Disease and Stroke The Economic Impact of Heart Disease and Stroke in the United States Deaths and disabilities from heart disease and stroke in 1998 cost the nation $286.5billion. beneficiaries whose stays due to heart disease and stroke involved a surgical procedurereceived $16.4 billion in payments. That amounted to $11,746 per discharge. The Cost of Living With Heart Disease or Stroke Some 58,800,000 people live with some form of heart disease or stroke. Treatment of these diseases accounts for $1 of every $6 spent on health care in the U.S. Direct medical costs. After a heart attack, there are immediate charges, such as: 1  Ambulance. 2  Diagnostic tests. 3  Hospital charges. 4  Possible surgery. Forexample, a person with heart disease is burdened by huge expenses, including diagnostictests, surgery, hospital and doctors’ visits, physical therapy, and costly drugs. Aconservative estimate of these costs for just one person is $121,200 over 20 years. The High Cost of Heart Disease. In 2010, the cost of cardiovascular disease in the U.S. was about $444 billion. That includes costs for treatment of: 1  Heart conditions. 2  Stroke. 3  Peripheral artery disease. In addition, the costs of absenteeism (days of lost work) due to cardiovascular disease fall between $23 million and $1.3 billion for each state yearly, the report said. • In 1996, the estimated first-year cost for a heart transplant was $253,200. Theestimated annual followup cost was more than $21,200. • Some 482,000 percutaneous transluminal coronary angioplasty procedures wereperformed in 1996. Between 1987 and 1996, these procedures increased by 211percent. The latest 2030 prevalence estimates for hypertension, coronary heart disease, heart failure, and stroke are derived from the 1999–2006 National Health and Nutrition Examination Survey (NHANES) and Census Bureau population estimates for the years 2010 to 2030. Total direct costs will increase to $818 billion by 2030, according to the AHA estimates, and the total indirect cost to the US in terms of lost productivity is close to $275 billion. Projections of Crude Cardiovascular Disease Prevalence (%). Year. At present, cardiovascular disease is the leading cause of death in the US and accounts for 17% of overall healthcare expenditures. In the past, the medical costs of cardiovascular disease increased at an average annual rate of 6%, and this growth in costs has been associated with an increase in life expectancy. That said, there are many opportunities to further improve cardiovascular health while controlling costs, according to the AHA.
About $444 billion